The shortage of iodinated contrast media that has rattled U.S. radiology since early May didn’t come from nowhere.

Two dozen academic physicians from around the U.S. with expertise in point-of-care ultrasound—and no vested interest in POCUS industry players—recently tested and compared four commercially available POCUS handhelds.

Experts observed significantly reduced pneumothorax and pulmonary hemorrhage rates of 8% and 6% when utilizing the method.

The FDA is notifying patients and referrers of another breast-imaging service’s slide into noncompliance with regulatory standards for image quality.

Fewer than 40% of rural counties in the U.S. can offer residents any access to point-of-care ultrasound, while nearly 90% of their metropolitan counterparts have POCUS aplenty. 

Beyond readmission, 32.9% of patients with increased pancreatic necrosis volumes required additional invasive interventions.

A clinical trial pitting MRI against a burgeoning PET/CT technique has found the de facto defending champion better at revealing the presence of any grade of prostate cancer.

Two emerging MRI techniques show promise as all-in-one imaging tests for patients with pain in and below the lower back due to changes in the sacroiliac joint.